Episode 333 • • 1:29:32 - 1:32:09
333: Lions Stood Still
Alzheimer's Drug Repurposing, Leukine Patent, Pharmaceutical Industry
The drug Leukine, originally for rheumatoid arthritis, is being promoted as a potential treatment for Alzheimer's disease. This "discovery" coincides with the drug's patent expiration in 2012. The hosts argue this is a common pharmaceutical industry tactic to repatent old drugs for new uses to prevent generic competition and maintain high prices.